Discovering Future Biotech Business Models: A Design Workshop for Executives

Discovering Future Biotech Business Models: A Design Workshop for Executives

Issued: Thu, 09 Mar 2017 10:03:00 GMT

The Adam Smith Business School invites executives and senior managers from the bioscience, biotech, life science and pharma industries to a one-day design workshop on exploring future business models. The objective of this workshop is to provide attendees with a tool-kit to evaluate, discover, and design innovative business models. The workshop is being organised by Dr Stephan Von Delft and Dr Yang Zhao of the Adam Smith Business School.

About the Workshop

Biotech and life science business models are at an important juncture today. The basic rules of the game for creating and capturing value, once fixed in place for years, are now subject to disruption, rapid displacement, and, in extreme cases, outright destruction. This requires executives to envision responses that go well beyond simply tinkering with the cost base or improving operational excellence. A bolder, more collaborative approach to discover and design new biotech and life science business models must become a critical element in the tool-kit of executives.

In “Discovering Future Biotech Business Models: A Design Workshop for Executives”, the Adam Smith Business School (ASBS) shares its structured process for business model innovation and then gives participants the tools to master each step. Based on research at ASBS, the programme shows how to communicate business model design more effectively to internal and external stakeholders, how to overcome barriers against business model innovation, and how to systematically improve a firm’s ability to sense business models in- and outside of the biotech and life science industry.

In this highly practical workshop, participants will learn about and apply tools and techniques to systematically evaluate, discover and design future biotech and life science business models.

Discovering Future Biotech Business Models Highlights & Benefits

  • Business model assessment, including implications of industry trends on established business models
  • Tools and techniques to identify new business models
  • Business model design, including the mapping skills to assemble winning business models
  • Opportunities and challenges of business model innovation, including practices to overcome barriers against business model innovation
  • Networking and training with a selected group of business leaders from the wider biotech and life science ecosystem

Programme

What

A highly practical, one-day workshop providing a tool-kit to evaluate, discover, and design new biotech and life science business models.

Who

Executives and senior managers from the Bioscience, biotechnology, pharma, and life science industries.

When

9.30am – 4.00 pm, 24th March 2017

Where

Room 305, Gilbert Scott Building

Adam Smith Business School, University of Glasgow

Agenda

  • Registration and networking breakfast
  • Kick-off, overview, ice-breaker
  • Provocation “Three things about your business model you should know, but don’t”
  • Evaluating existing biotech business models: 1.) Interactive team break outs, 2.) De-briefing: team share outs
  • Networking lunch
  • Provocation “The hard truth about business model innovation”
  • Discovering new biotech business models: 1.) Interactive team break outs, 2.) De-briefing: team share outs
  • Afternoon tea
  • Provocation “Worried about business model implementation?”
  • Designing new biotech business models: 1.) Interactive team break outs, 2.) De-briefing: team share outs
  • Discussions, synthesis, conclusions

About the Organisers

Dr Stephan von Delft

Stephan is a Lecturer in Strategy at the University of Glasgow’s Adam Smith Business School, UK. Prior to joining Glasgow, he was a Post-Doctoral Researcher at the University of Amsterdam Business School, the Netherlands, and a Visiting Researcher at the University of San Diego’s School of Business Administration, USA. He received his PhD from the University of Muenster’s Department of Chemistry and Pharmacy, Germany. In his research, he focuses on the antecedents and consequences of business model design and business model innovation. To translate his research into impact and to interactively develop his research agenda, Stephan regularly collaborates with industry partners, particularly in the chemical and pharmaceutical industry, resulting in an active interface with key non-academic stakeholders of his research. For example, he has worked with new business development teams at BASF and Evonik Industries, and collaborated with the German Chemical Industry Association, the Rhine Main Chemicals & Pharmaceuticals Cluster (e.g., Sanofi) and PwC Strategy& in a business model design project. Currently, he is involved in a Knowledge Transfer Partnership (KTP) on business model innovation with a Scottish company.

Dr Yang Zhao

Yang is a Lecturer in Entrepreneurship at the University of Glasgow’s Adam Smith Business School, where she also obtained her PhD. In her research, Yang focuses on the dynamic process of business model evolution and the associated firm performance of entrepreneurial companies. In her research, she intensively collaborates with entrepreneurial start-ups, particularly in the e-commerce industry, exploring the design and development of their business models. To translate her research into impact, Yang also closely engages with industrial partners, industrial associations, and government organisations. For example, Yang collaborated with twelve start-ups in the Online Group Buying industry, examining their innovative approaches to create business models in a highly competitive market. Recently, Yang is involved in a project that explores how Sottish entrepreneurial firms like Skyscanner develop their business models by transferring knowledge between UK and overseas markets.


For more information and registration please go to: https://www.eventbrite.co.uk/e/discovering-future-biotech-business-models-tickets-32499382528

<< Events